Literature DB >> 15887866

Intrahepatic cholestasis as a paraneoplastic syndrome associated with pheochromocytoma.

C H Chung1, C H Wang, C Y Tzen, C P Liu.   

Abstract

Pheochromocytoma is a rare tumor of chromaffin cells that secrete catecholamines and several cytokines. The clinical manifestations are protean and may include hypertension, weight loss, sweating, palpitation, headache, anxiety, tremor, nausea, vomiting, and hypercalcemia. The tumor can mimic many unrelated diseases, leading to significant delay and difficulty in diagnosis. We report a case of a 37-yr-old male admitted with jaundice, dark urine, fever, and signs of a systemic inflammatory response. Abdominal computed tomography revealed a heterogeneously enhancing tumor between the pancreatic tail and left kidney. There was no evidence of obstruction to bile flow, neoplastic involvement of the liver or bile ducts, or infectious etiology. The tumor was removed and found to be a pheochromocytoma. Immunohistochemical analysis revealed the presence of interleukin-1beta in the tumor cells. After surgery, the jaundice resolved without further treatment, leading us to the conclusion that it was a paraneoplastic phenomenon possibly related to interleukin-1beta production. We suggest that occult pheochromocytoma should be added to the differential diagnosis of unexplained intrahepatic cholestasis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15887866     DOI: 10.1007/bf03345363

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  38 in total

1.  Secretion of vasopressin from a human pheochromocytoma.

Authors:  G Boccara; C Mann; G Guillon
Journal:  Ann Intern Med       Date:  1998-06-15       Impact factor: 25.391

2.  Extrahepatic Hodgkin's disease with intrahepatic cholestasis: report of two cases.

Authors:  S Yalçin; A Kars; C Sökmensüer; L Atahan
Journal:  Oncology       Date:  1999-07       Impact factor: 2.935

3.  Progressive hepatic failure. Its association with undifferentiated renal tumor.

Authors:  W H Summerskill; R G Shorter
Journal:  Arch Intern Med       Date:  1967-07

4.  Interleukin-2 induces profound reversible cholestasis: a detailed analysis in treated cancer patients.

Authors:  B Fisher; A M Keenan; B S Garra; S M Steinberg; D E White; A M DiBisceglie; J H Hoofnagle; P Yolles; S A Rosenberg; M T Lotze
Journal:  J Clin Oncol       Date:  1989-12       Impact factor: 44.544

5.  Expression of interleukin-1 in human pheochromocytoma.

Authors:  S R Bornstein; M Ehrhart-Bornstein; J González-Hernández; S Schröder; W A Scherbaum
Journal:  J Endocrinol Invest       Date:  1996-11       Impact factor: 4.256

6.  KAT45 human pheochromocytoma cell line. A new model for the in vitro study of neuro-immuno-hormonal interactions.

Authors:  M Venihaki; A Gravanis; A N Margioris
Journal:  Ann N Y Acad Sci       Date:  1998-05-01       Impact factor: 5.691

7.  Focal pancreatic infarction in pheochromocytoma.

Authors:  A al-Dawoud; W R Murray; M C Allison
Journal:  Dig Dis Sci       Date:  1993-07       Impact factor: 3.199

8.  Tumor necrosis factor-alpha decreases hepatocyte bile salt uptake and mediates endotoxin-induced cholestasis.

Authors:  J F Whiting; R M Green; A B Rosenbluth; J L Gollan
Journal:  Hepatology       Date:  1995-10       Impact factor: 17.425

9.  Pheochromocytoma: 1926-1993.

Authors:  W F Young
Journal:  Trends Endocrinol Metab       Date:  1993 May-Jun       Impact factor: 12.015

10.  Interleukin-6 inhibits hepatocyte taurocholate uptake and sodium-potassium-adenosinetriphosphatase activity.

Authors:  R M Green; J F Whiting; A B Rosenbluth; D Beier; J L Gollan
Journal:  Am J Physiol       Date:  1994-12
View more
  3 in total

1.  Synergistic effects between CA1 mu opioid and dopamine D1-like receptors in impaired passive avoidance performance induced by hepatic encephalopathy in mice.

Authors:  Mohammad Nasehi; Samaneh Amin Yavari; Mohammad Reza Zarrindast
Journal:  Psychopharmacology (Berl)       Date:  2013-02-13       Impact factor: 4.530

2.  Paraneoplastic Hepatopathy Associated with Gastrointestinal Carcinoid.

Authors:  Dhruv Mehta; Priyanka Chugh; Lavneet Chawla; Daniela Jodorkovsky
Journal:  ACG Case Rep J       Date:  2017-11-08

3.  Cholestatic Hepatitis as a Possible Paraneoplastic Syndrome of Endometrial Carcinoma.

Authors:  Francis Gerald Wade; Florence-Damilola Odufalu; Charlene Prather; Elizabeth Marsicano
Journal:  ACG Case Rep J       Date:  2020-03-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.